Patrick Campbell (@RealPatCampbell) header
Patrick Campbell (@RealPatCampbell) profile picture
New Jersey
Joined May 2011
Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)Photo by Patrick Campbell (@RealPatCampbell)
Patrick Campbell retweeted
🚨 BREAKING: The @FDA has approved gefurulimab-gaks (Klygefa; @AlexionPharmaUS ) for adults with anti-AChR antibody-positive generalized myasthenia gravis (#gMG) 💉 The once-weekly, self-administered subcutaneous C5 inhibitor was approved based on phase 3 PREVAIL findings 🧠 Read about the approval here: neurologylive.com/view/fda-a… #Neurology #FDA
2
3
307
Patrick Campbell retweeted
The HCPLive team is in Chicago for #AHA26! Be sure to follow along for the latest in cardiology: hcplive.com #cardiology
1
2
76
A common theme on the podcast has been imposter syndrome and @robmentz gives a fantastic perspective on that. Very relevant for trainees and early-mid career faculty. Lesson: it’s ok to feel vulnerable. You’re not alone.
2
5
21
1,408
Patrick Campbell retweeted
Day 1🗓️ of #GOLD2026 starts today in Philadelphia! HCPLive is on-site, covering topics like mucus plugging, exacerbation definitions, and more ahead of the 2027 GOLD Report. Follow along: hcplive.com/view/conference-…
1
75
Patrick Campbell retweeted
In this episode of #ABCsInDermatology, hosts highlight how the standard of care for atopic dermatitis is undergoing a transformative shift beyond managing symptoms to actually achieving optimal treatment targets. hubs.li/Q04CSgHr0
1
1
3
111
Patrick Campbell retweeted
⏱️ #WorldStrokeDay: @snellingmd, of @BaptistHealthSF, says delays before the 911 call remain a major gap in stroke care. He discusses atypical symptoms, BE FAST, and reaching underserved populations. 🚨 hubs.li/Q04CP8Vk0 #Stroke #Neurology
2
1
338
Big news from day 1 of #KidneyWeek2026. Data from phase 2 and phase 3 trials of retatrutide, sibeprenlimab, telitacicept, and iptacopan headline the meeting's first day. hcplive.com/conference/asn #KidneyWk #NephTwitter #Nephrology
3
5
533
Patrick Campbell retweeted
📍 We’re on the ground for #MSToronto2026 ‼️ 🇨🇦 ✍️ Coverage kicks off tomorrow, with key updates, expert insights, and the latest developments in #MS 🧠 Follow along with NeurologyLive as we bring you the stories and perspectives shaping the MS treatment landscape! 🔗 Stay tuned to our social channels and hubs.li/Q04BQHzC0 for the latest updates! 👀 #MSToronto #Clinical #MSCare
1
202
Patrick Campbell retweeted
From medication habits that may be fueling asthma exacerbations to what sputum color can tell you in bronchiectasis, here are the day 1 headlines from #CHEST2026 @accpchest worth knowing. #asthma #COPD #bronchiectasis #ildahumic #pulmonology Read here: hcplive.com/view/chest-2026-… – at Phoenix, AZ
1
3
3
1,644
Patrick Campbell retweeted
🇨🇦 🧠 Bonjour from Montreal, Canada! We are here for Day 1 of the 2026 Child Neurology Society Annual Meeting! Be on the lookout for our coverage of #CNSAM 2026, featuring expert interviews and the latest data in child neurology! 🔎 📊 @ChildNeuroSoc
2
7
360
Patrick Campbell retweeted
All the latest data on neuromuscular disorders, electrodiagnostic medicine, and more. Here, at the 2026 #AANEM Annual Meeting in Orlando, FL ☀️🌴 @AANEMorg Our coverage rolls on: neurologylive.com/conference…
1
210
Patrick Campbell retweeted
🧠 @FDA accepts NDA under priority review for @genentech's fenebrutinib, an oral BTK inhibitor, in both relapsing and primary progressive MS, backed by 3 phase 3 trials vs teriflunomide and ocrelizumab. hubs.li/Q04yKx790 #MultipleSclerosis #Neurology
2
1
319
Patrick Campbell retweeted
For those attending #AANEM2026, here's a look at some of the top trending stories we've covered 👇 🏥 Gefurulimab Cuts Hospitalizations, Sustains Response in Phase 3 PREVAIL Trial of Myasthenia Gravis - neurologylive.com/view/gefur… 📈 Inebilizumab Shows Durable Benefit in MuSK+ Generalized Myasthenia Gravis - neurologylive.com/view/inebi… 💉 Zilucoplan Autoinjector Matches Bioequivalence of Pre-Filled Syringe in MG - neurologylive.com/view/ziluc… 📊 New Phase 3 Trials to Test Empasiprubart Against Placebo, IVIG in CIDP - neurologylive.com/view/empas… For all AANEM coverage, click here: neurologylive.com/conference…
2
1
324
Patrick Campbell retweeted
Vienna, here we come. 🇦🇹 Tomorrow, HCPLive's coverage of #EADV2026 kicks off. Starting Sept 30, expect expert interviews, late-breaking data, and more. Follow along for dermatology updates you won't want to miss: hcplive.com/conference/europ…
1
4
258
Patrick Campbell retweeted
Advocacy isn't separate from patient care. It's part of it. AAD President Murad Alam, MD, joins Elizabeth Kiracofe, MD, on the Skin of Color Savvy podcast 🎙️ to explain why. 🎧More: hcplive.com/view/reimburseme…
1
3
231
Patrick Campbell retweeted
A major step forward in type 1 diabetes care: Tzield is now approved for children as young as 1. #Type1Diabetes #FDA #PediatricHealth #Diabetes #EarlyIntervention #T1D Watch our interview with diabetes expert Rachael Sood, NP-C, to learn more about what this means for families: hubs.li/Q04d4Mc30
2
93